Back Refine search Reset
Please choose a search criteria from below
Filters Clear all
Specialties
Treatments

85 results found in London

Sort by:
Showing 31 - 40 of 85 results
Oncology
25 years of experience
Advanced Melanoma, Medical Oncology, Renal Cancer + 1more

Dr Paul Nathan is an internationally renowned and well-respected Consultant Medical Oncologist with HCA Healthcare at LOC, The Harley Street Clinic, and The Wellington Hospital. His NHS practice is based at Mount Vernon Cancer Centre and UCLH. Dr Nathan’s clinical interests include melanoma of the skin, eye, and internal organs; kidney cancer (renal cell carcinoma), and rare skin cancers including Merkel cell carcinoma.

He originally trained in cancer immunology as a scientist, and following his Ph.D. and post-doctoral position in Pittsburgh, he ran a tumor immunology laboratory in the pharmaceutical industry. He then pursued clinical studies at Cambridge and UCL.

Dr Nathan has been a Consultant Medical Oncologist for nearly 20 years. He remains heavily involved in research and is the lead investigator for many clinical trials, particularly in the field of immunotherapy and targeted therapies. Most recently he has led the development of tebentafusp, the first drug proven to improve survival in advanced uveal melanoma. Dr Nathan has published over 100 papers, many of which are in the world’s leading medical journals, and has contributed to a number of medical textbooks. He is the Chair of the UK Uveal Melanoma Guidelines group and the UK Lead for Uveal Melanoma at the International Rare Cancer Initiative. He also leads the melanoma systemic therapies for the European cancer organisation’s (EORTC) melanoma group. Previously, Dr Nathan chaired the NCRI renal cancer clinical studies group. 

 


Diseases, Medical Tests and Treatments

  • Immunotherapy
  • Chemotherapy
  • Urological Cancer
  • Kidney Cancer
  • Renal Cancer
  • Skin Cancer
  • Melanoma
Read more
Oncology
Offers video consultation
34 years of experience
Medical Oncology, Bladder Cancer, Lung Cancer + 4more

Dr Jonathan Shamash is a Consultant Oncologist and is the Lead in Acute Oncology at St Bartholomew’s Hospital and has a further NHS base at Queen’s Hospital, Romford. Dr Shamash also sees patients privately, including at Leaders in Oncology Care. He graduated from the University of Edinburgh in 1987 and then undertook post graduate training in London, gaining an MD in in-vitro modelling of lymphoma.

Dr Shamash sub-specialises in genito-urinary cancers and thoracic malignancies. He has a special interest in managing complex oncology problems and delivering intensive treatments, including high dose Interleukin-2 and high does chemotherapy in testicular cancer. . Dr Shamash also chairs the supra-regional germ cell tumour multidisciplinary meeting and is a member of the NCRI testis clinical studies group. He leads various clinical studies in the management of testicular and prostate cancer and has published widely.

Read more
Oncology
24 years of experience
Clinical Oncology

Dr Simon Hughes is Consultant Clinical Oncologist at Guy’s and St Thomas’ NHS Foundation Trust, and an Honorary Senior Lecturer at King’s College London School of Medical Education (GKT Medical School). He specialises in the treatment of Urological cancers: Bladder Cancer, Prostate Cancer and Radiotherapy for other Urological Cancers. Simon Hughes trained at Guy’s and St Thomas’ Hospitals Medical School, where he also gained a BSc with First Class honours (Anatomy). His specialist training in Clinical Oncology included posts at The Middlesex Hospital, University College London Hospitals, and Guy’s & St. Thomas’ Hospitals. He also spent over 2 years working in the Imaging Sciences Laboratories at Kings College London, and the Centre for Medical Image Computing at University College London developing novel radiotherapy techniques for the treatment of mobile tumours.


Simon continues to have an active role in Research and Development. He led the Clinical Oncology and Radiotherapy Research and Development Team at Guy’s and St. Thomas’ Hospitals for 5 years, and was also Radiotherapy Clinical Trials Lead for the South East London Cancer Network during this period. His research interests include tumour motion, radiotherapy dose escalation, integration of functional imaging into radiotherapy planning, and the combination of novel agents with radiotherapy. He is the UK lead for the ENZARAD Study, and is a member of several Trial Management Groups / Data Monitoring Committees. Simon’s other main interest is medical education. He is the Education and Training Lead for King’s Health Partners Comprehensive Cancer Centre; an Associate Clinical Dean at King’s College London School of Medical Education; and is the Clinical Education and Training Lead for King’s College London School of Cancer and Pharmacological Sciences. Nationally, Simon is the Treasurer for the British Uro-oncology Group; and was the co-opted oncologist for the British Association of Urological Surgeons: Oncology Section Committee from 2013-2017. He is also a past President of the Oncology Section of the Royal Society of Medicine (2011-2012), and served on council for over 10 years.


Diseases, Medical Tests and Treatments
  • Bladder Cancer
  • Prostate Cancer
  • Radiotherapy for other Urological Cancers
  • SABR / Cyberknife (for Urological Cancers)
  • Radionuclide Therapy (for Urological Cancers)
  • Bladder Cancer
  • Prostate Cancer
  • Radiotherapy for other Urological Cancers
  • SABR / Cyberknife (for Urological Cancers)
  • Radionuclide Therapy (for Urological Cancers)
Read more
Oncology
26 years of experience

Dr Laura Kenny is a Consultant in Medical Oncology and she specialises in breast cancer. She trained in medicine at Queen's University Belfast and after following initial registrar training, she moved to London to study for a PhD in translational molecular imaging in the Cyclotron Building, Imperial College London. Her NHS clinical practice is based at Charing Cross and Hammersmith Hospitals (part of Imperial College  Healthcare NHS Trust) and she also sees patients privately. In addition, Dr Kenny is a Clinical Senior Lecturer at Imperial College.

Dr Kenny was awarded a Westminster Medical School Oncology Trustee's fellowship and her research has focused on the use of novel PET radiotracers for studying proliferation (fluorothymidine (FLT)), angiogenesis (fluciclatide (AH-111585), and choline metabolism in breast cancer patients. Her work has been published in Cancer Research, Clinical Cancer Research, the Journal of Nuclear Medicine, and the European Journal of Molecular Imaging and Nuclear Medicine.

She was awarded a prestigious NIHR/MRC clinician scientist fellowship  in 2010, with the aim of the project being to establish new methods for defining the imaging phenotype in patients, which will help predict drug resistance and drug sensitivity at early timepoints to established and novel cancer therapeutic agents.  Her research has been recognised by the American Association of Cancer Research (Young Investigator Award), American Society of Clinical Oncology (Merit Award), British Cancer Research Meeting (Translational Research Award), and she also won the McElwain prize.

Dr Kenny was also appointed as Director of  Early Phase Clinical Trials in Cancer, where her aim is to expedite clinical drug development with novel approaches to clinical trials. She was also awarded an MRC DPFS project grant to study a new Affibody probe which will target her2 expression in breast cancer, this will be a first in man study and involves collaboration with four leading oncology centres in the UK. 


Diseases, Medical Tests and Treatments
  • Chemotherapy
  • Breast Cancer
Read more
Oncology
30 years of experience
Clinical Oncology

Dr Teresa Guerrero Urbano is a Consultant Clinical Oncologist and clinical lead for Radiotherapy at Guy’s and St Thomas’ NHS Foundation Trust and King’s College, London. She is honorary Senior Lecturer at the University of Surrey. Her areas of expertise include: Head & Neck Cancer, Non melanomatous skin cancer and Prostate cancer. Dr Guerrero Urbano has previously held senior Consultant Clinical Oncologist and Honorary Senior Lecturer positions at Royal Surrey County NHS Trust, Basingstoke and North Hampshire NHS Foundation Trust, University of Surrey. She was a Senior Research Fellow at University College London and a Clinical Cancer Research Fellow at the Institute of Cancer Research and Royal Marsden Hospital.

Dr Guerrero Urbano completed her oncology training at the Royal Marsden, Royal Surrey County and Guy’s and St Thomas’ Hospitals. She completed her PhD at the University of London in 2008. Dr Guerrero Urbano is joint Module Leader for the Respiratory, Head and Neck module, MSc in Oncology, Institute of Cancer Research. She offers weekly Oncology Seminars at St Luke’s Cancer Centre aimed at doctors, nurses, radiographers and physicists and monthly lectures at the post-graduate Medical School at the University of Surrey. She is a PhD and MD examiner. Her formal research evaluated technical and biological aspects of intensity-modulated radiotherapy at the Institute of Cancer Research/Royal Marsden Hospital. Dr Guerrero Urbano is particularly interested in the use of novel radiation techniques to minimize long-term side effects and the use of chemotherapy and targeted therapy to improve outcomes. Dr Guerrero Urbano has published her research widely and spoken at conferences worldwide.


Diseases, Medical Tests and Treatments
  • Head and neck cancer
  • Technical and biological aspects of image-guided radiotherapy (IGRT)
  • Intensity-modulated radiotherapy (IMRT)
  • Cancer imaging applied to radiotherapy treatments
  • Head and neck cancer
  • Technical and biological aspects of image-guided radiotherapy (IGRT)
  • Intensity-modulated radiotherapy (IMRT)
  • Cancer imaging applied to radiotherapy treatments
Read more
Oncology
15 years of experience
Breast Cancer, Medical Oncology

Dr Mark Nathan is a Consultant Medical Oncologist at Guy’s and St Thomas’ NHS Foundation Trust having joined in 2017.

He specialises in treating breast cancer, working at Guys Hospital as well as Kings Hospital and Queen Mary’s Hospital in Sidcup. He is involved in the running of clinical trials at Guys Hospital.

Dr Nathan originates from London and graduated from the Bart’s and the London Medical School in 2006. He undertook his basic training in and around North East London before returning to complete his higher Oncology training at St Bartholomew’s Hospital.

He spent three years obtaining his PhD as an AVON clinical research fellow at the Breakthrough Breast Cancer Research Centre where he also participated in clinics at the Royal Marsden Hospital.


Diseases, Medical Tests and Treatments
  • The management of early and metastatic breast cancer
  • The management of early and metastatic breast cancer
Read more
Haematology
Recommended by 3 specialists
19 years of experience
Haematological Malignancy

Dr Jonathan Sive is a Consultant Haematologist and Clinical Service Lead for Myeloma at University College London Hospital (UCLH). He is highly experienced in the diagnosis and management of blood cancers, particularly in myeloma and other plasma cell disorders such as MGUS, plasmacytomas and POEMS Syndrome. He also has expertise in the investigation of anaemia and other abnormal blood counts.

He is an executive member of the UK Myeloma Forum where he coordinates myeloma management and guidelines at a national level. He is the lead author of the recently published UK national guidelines on the diagnosis and initial treatment of myeloma. He is also an active member of the UK Myeloma Research Alliance where he is involved in the planning and management of national clinical trials

Dr Sive completed his specialist haematology training at UCLH and carried out a PhD in Molecular Haematology at Cambridge University, for which he was awarded a Cancer Research UK Clinical Fellowship. He remains actively engaged in a variety of clinical research projects and his work has been widely published in peer-reviewed journals and textbooks.

Dr Sive is dedicated to improving outcomes and wellbeing for his patients, and combines professional, expert advice with a caring and sympathetic manner. He is registered as a provider with all major UK insurance companies and is also happy to see uninsured self -pay patients.

Diseases, Medical Tests and Treatments

  • Investigation and treatment of myeloma
  • Mnagament of other plasma cell abnormalities such as MGUS, Plasmacytomas and POEMS Syndrome
  • Investigation and management of anaemia and other blood count abnormalities
  • Myeloma and other plasma cell disorders (MGUS, plasmacytomas, POEMS Syndrome).
  • Blood cancers
  • General haematology
  • Investigation and management of anaemia
  • High and low white cell counts
  • Neutropenia
  • High and low platelet counts
  • Iron deficiency and paraproteins
Read more
Oncology
18 years of experience
Medical Oncology

Dr Nikos Diamantis is a Medical Oncology Consultant at St Bartholomew's Hospital specialising in colorectal, oesphageal, gastric, pancreatic, liver and bile duct cancers, and cancers of unknown primary. He is the Barts Trust Lead for Acute Oncology and Cancer of Uknowon Primay.

Dr Diamantis underwent specialist training at the Imperial College Healthcare Hammersmith, St Mary's and Harefield Hospitals. He was awarded the Greek national Oncology fellowship scholarship and went on to conduct clinical research for 2 years at the Drug Development Unit of the Royal Marsden.

Research interests include immunotherapy for GI malignancies and first in human clinical trials. Dr Diamantis is a Principal Investigator for a number of Phase 2 and 3 trials.



.

Read more
Oncology
43 years of experience
Breast Cancer, Clinical Oncology, Prostate Cancer

Dr Stephen Karp is a Consultant Clinical Oncologist at North Middlesex Hospital. His preclinical studies were at King’s College London where he also obtained an intercalated BSc in Pharmacology (1st Class Honours). He graduated in Medicine from Westminster Hospital Medical School in 1979 with a distinction in Surgery. His postgraduate training included cardiology at Hammersmith Hospital and neurology at the National Hospital Queen Square as well as general medicine at Whittington Hospital. He was a gastroenterology registrar at Northwick Park Hospital and trained in clinical oncology at the Middlesex Hospital and Mount Vernon Hospital.

Although Dr Karp was trained and initially practised in almost all areas of oncology, he is now specialized in treating cancers of the breast, GI tract (colorectal, oesophagogastric, pancreatic) and urological cancer (prostate and bladder cancer) with chemotherapy, hormone therapy, biological therapy and radiotherapy, including Cyberknife and SABR.


Diseases, Medical Tests and Treatments

  • Breast, gastrointestinal and prostate cancer (chemotherapy and radiotherapy)
  • IMRT IGRT
  • SABR
  • Cyberknife
  • Chemotherapy
  • Hormone therapy
  • Immunotherapy
  • Biological therapy
  • Breast, gastrointestinal and prostate cancer (chemotherapy and radiotherapy)
Read more
Haematology
22 years of experience
Haematological Malignancy

Dr Ian Gabriel is a Consultant Haematologist and the Lead Clinician at Chelsea and Westminster Hospital and he is also a Stem Cell (Bone Marrow) Transplant Consultant at Imperial College. Dr Gabriel sees patients privately at a number of locations, including the Lister and the London Bridge Hospitals.

Dr Gabriel qualified in medicine from St Mary’s Hospital Medical School – Imperial College in 1999 and completed specialist training in haematology in London. He has a Joint Consultant position with Imperial College NHS Healthcare Trust (Hammersmith Hospital) where he specialises in haemato-oncology (myeloma) and stem cell transplantation and at Chelsea and Westminster, where he leads the service for blood cancers, including myeloma, lymphoma, myelodysplasia and leukaemia. He completed research for his PhD in transplant immunology.

Dr Gabriel is also one of the leading clinicians for stem cell treatment for multiple sclerosis, leading the service at Imeprial College. He is a founding member of the European Consortium for Stem Cell Mobilisation (ECOSM), a member of the European Blood and Marrow Transplant Group (EBMT) autoimmune disease and acute leukaemia working parties. He is also primary and co-investigator on a number of national and international clinical trials in haematology. Further he runs a general haematology clinic, including for anti-coagulation conditions. He has published numerous peer reviewed papers on lymphoma, myeloma, leukaemia and HIV haematology, in addition to those on stem cell transplantation and authored a number of book chapters.

 


Diseases, Medical Tests and Treatments
  • Stem Cell Transplantation
  • Stem Cell Transplantation for Multiple Sclerosis
  • Lymphoma
  • Leukaemia
  • Multiple Myeloma
  • Myelodysplasia
  • Haematological Malignancy Conditions

 

 

Read more